Kodiak Sciences (KOD) Preferred Stock Liabilities (2017 - 2018)
Kodiak Sciences (KOD) posted Preferred Stock Liabilities of $50.0 million for Q3 2018, little changed on a QoQ basis from $50.0 million in Q4 2017.
Kodiak Sciences (KOD) Preferred Stock Liabilities (2017 - 2018) Analysis & Trends
Kodiak Sciences' Preferred Stock Liabilities history runs 2 years deep, the most recent figure standing at $50.0 million for Q3 2018.
- Quarterly Preferred Stock Liabilities changed N/A year-over-year to $50.0 million in Q3 2018, while the trailing twelve-month figure through Sep 2018 was $50.0 million (changed N/A YoY) and the FY2017 annual result came in at $50.0 million, changed 0.0% from the prior year.
- Preferred Stock Liabilities was $50.0 million for Q3 2018 at Kodiak Sciences, roughly flat from $50.0 million in the prior quarter.
- Across five years, Preferred Stock Liabilities topped out at $50.0 million in Q4 2017 and bottomed at $50.0 million in Q4 2017.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Preferred Stock Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | - |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | - |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | - |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | - |
| 10 | Kodiak Sciences | 2.54 Bn | 2.54 Bn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2018 | 50.02 Mn |
| Dec 31, 2017 | 50.02 Mn |